Top Markets
Coin of the day
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation

GlobeStar Therapeutics Corporation

GSTC
Rangering i aksjer #40541
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm... GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-12
Markedsverdi
$124.11K
Endring (1 dag)
0.00%
Endring (1 år)
9,900.00%
Land
US
Handel GlobeStar Therapeutics Corporation (GSTC)

Kategori

EPS for GlobeStar Therapeutics Corporation (GSTC)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til GlobeStar Therapeutics Corporation er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for GlobeStar Therapeutics Corporation fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter